DE1493146A1 - Verfahren zur Herstellung von 1,5-Bisdenydrosteroiden - Google Patents

Verfahren zur Herstellung von 1,5-Bisdenydrosteroiden

Info

Publication number
DE1493146A1
DE1493146A1 DE19641493146 DE1493146A DE1493146A1 DE 1493146 A1 DE1493146 A1 DE 1493146A1 DE 19641493146 DE19641493146 DE 19641493146 DE 1493146 A DE1493146 A DE 1493146A DE 1493146 A1 DE1493146 A1 DE 1493146A1
Authority
DE
Germany
Prior art keywords
keto
alkali metal
isomerization
dione
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19641493146
Other languages
German (de)
English (en)
Inventor
Shapiro Elliot L
Oliveto Eugene P
Masato Tanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US251744A external-priority patent/US3127428A/en
Priority claimed from US251747A external-priority patent/US3127430A/en
Priority claimed from US263441A external-priority patent/US3332967A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of DE1493146A1 publication Critical patent/DE1493146A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
    • A63F1/00—Card games
    • A63F1/06—Card games appurtenances
    • A63F1/18—Score computers; Miscellaneous indicators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Multimedia (AREA)
  • Steroid Compounds (AREA)
DE19641493146 1963-01-16 1964-01-14 Verfahren zur Herstellung von 1,5-Bisdenydrosteroiden Pending DE1493146A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US251744A US3127428A (en) 1963-01-16 1963-01-16 Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound
US251747A US3127430A (en) 1963-01-16 1963-01-16 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US263441A US3332967A (en) 1963-01-16 1963-03-07 3-hydroxy-1, 5-bis-dehydro steroids and methods for their manufacture
US31227363A 1963-09-30 1963-09-30

Publications (1)

Publication Number Publication Date
DE1493146A1 true DE1493146A1 (de) 1969-08-07

Family

ID=27500405

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19641493146 Pending DE1493146A1 (de) 1963-01-16 1964-01-14 Verfahren zur Herstellung von 1,5-Bisdenydrosteroiden

Country Status (4)

Country Link
CH (1) CH452513A (enrdf_load_html_response)
DE (1) DE1493146A1 (enrdf_load_html_response)
DK (1) DK114971B (enrdf_load_html_response)
SE (1) SE314366B (enrdf_load_html_response)

Also Published As

Publication number Publication date
CH452513A (de) 1968-03-15
SE314366B (enrdf_load_html_response) 1969-09-08
DK114971B (da) 1969-08-25

Similar Documents

Publication Publication Date Title
DE3741801A1 (de) 17-methylen-estratriene
DE3402330A1 (de) 1(alpha),2(alpha)-methylen-6-methylen- und 6(alpha)-methyl-pregnene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE1468905C3 (de) Verfahren zur Herstellung von 3 beta, 6 beta-Dihydroxy-(bzw. Diacyloxy> Delta hoch 5(10) -19-nor-Steroiden und einige dieser Verbindungen
DE1568308B2 (de) Verfahren zur herstellung von delta hoch 4,9,11-trienen der 19-nor- androstanreihe, 17-oxygenierte 3-oxo- 7 alpha-methyl-delta hoch 4,9,11-19 nor- androstatriene und diese enthaltende pharmazeutische praeparate sowie 3-oxo-7 alpha -methyl-delta hoch 5 (10), 9 (11) -19-nor- androstadiene
EP0430386B1 (de) 14Alpha, 17alpha-überbrückte 16-Hydroxyestratriene
CH494216A (de) Verfahren zur Herstellung von in 3-Stellung einer verätherte Hydroxygruppe tragenden 6-Aminomethyl- 3,5-steroiden
DE1493146A1 (de) Verfahren zur Herstellung von 1,5-Bisdenydrosteroiden
DE1793618C3 (de) 07.03.63 USA 263441 Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden der Androstanreihe
CH498818A (de) Verfahren zur Herstellung von neuen 17a-Alka-1',3'-diinyl-17B-hydroxy-steroiden
DE2047071C3 (de) pregnadiene, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2336431C2 (de) 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE1493145C (de) In 4-Stellung unsubstituierte 3-Hydroxy-1,5-bisdehydro-steroide der Androstanreihe
DE1923378C3 (de) 1 alpha, 2alpha, 6beta, 7beta-Dimethylensteroide Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DEU0001986MA (enrdf_load_html_response)
DE1593687C (de) Verfahren zur Herstellung von neuen Benzo eckige Klammer auf d,e eckige Klam mer zu steroiden der Androstan und Preg nanreihe
DE1815488A1 (de) Neue pharmazeutisch wirksame 18-Methylensteroide und Verfahren zur Herstellung von 18-Methylensteroiden
DE1219933B (de) Verfahren zur Herstellung von 1-Methyl-1, 3, 5(10)-oestratrien-derivaten
DE2218413A1 (de) Herstellung neuer 6 alpha, 9 alpha-Difluorsteroide der Pregnanreihe
DE1199263B (de) Verfahren zur Herstellung von 17-(2-Alkenyl)-bzw. 17-(2-Alkinyl)-oestra-1, 3, 5(10)-trien-3, 17beta-diolen sowie von deren Estern
DE1144270B (de) Verfahren zur Herstellung neuer anabolisch und progestativ wirkender ?-3-Keto-6-methyl-19-norsteroide
DE1095278B (de) Verfahren zur Herstellung von 6ª‰-Hydroxysteroiden
DE1085873B (de) Verfahren zur Herstellung von 6-Methyl-17 ª‡, 21-dioxy-1, 4-pregnadien-3, 20-dionen und deren 21-Acylaten
CH601344A5 (en) C-17-C-3' disteroidyl-ethers
CH531496A (de) Verfahren zur Herstellung von 18-Methylensteroiden
DE1493093A1 (de) Neue Steroidverbindungen und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
SH Request for examination between 03.10.1968 and 22.04.1971